Cláudia Cristina Ferreira Vasconcelos

Author

Universidade Federal do Estado do Rio de Janeiro ORCID

Also Known As

Allan Kermode, C C F Vasconcelos, C VASCONCELOS, C Vasconcelos, C. C. Vasconcelos, C. C.F. Vasconcelos, C. Vasconcelos, C.C. Ferreira Vasconcelos, C.C.F. Vasconcelos, Camilly Campos Vasconcelos

139

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Universidade Federal do Estado do Rio de Janeiro Universidade Federal do Rio de Janeiro Universidade do Estado do Rio de Janeiro Instituto Nacional do Câncer Universidade Federal Fluminense

About

Cláudia Cristina Ferreira Vasconcelos is an author at Universidade Federal do Estado do Rio de Janeiro specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	17	1.1K
2	Public Health	6	6	686
3	Social Sciences	2	2	143
4	Cell Biology	1	1	18
5	Emergency Medicine	1	1	32

Cláudia Cristina Ferreira Vasconcelos

Publications

Citations

H-Index

Page 1

	Year	Citations
Planning cancer control in Latin America and the Caribbean Paul E. Goss, Brittany Lee, Tanja Badovinac-Črnjević, The Lancet Oncology Preventive MedicineMedicineGlobal HealthEpidemiology Of CancerCancer Prevention	2013	496
SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice Fabrícia Lima Fontes-Dantas, Gabriel Gripp Fernandes, Elisa Gouvea Gutman, Cell Reports	2023	154
Outcomes of Breast Cancer in Brazil Related to Health Care Coverage: A Retrospective Cohort Study Pedro Emanuel Rubini Liedke, Dianne M. Finkelstein, Jackie Szymonifka, Cancer Epidemiology Biomarkers & Prevention	2013	110
Cannabinoids in neurology – Brazilian Academy of Neurology Sônia Maria Dozzi Brucki, Norberto Anísio Frota, Pedro Schestatsky, Arquivos de Neuro-Psiquiatria NeuropsychologyNeurological ConditionsSão PauloPsychopharmacologyCannabinoid Pharmacology	2015	95
Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4<sup>+</sup> T‐cell subsets in multiple sclerosis patients Priscila M. Sacramento, Clarice Monteiro, Aleida Dias, European Journal of Immunology	2018	90
Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase Priscila O. Barros, Tommaso Cassano, Joana Hygino, Clinical & Experimental Immunology	2015	80
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis Yára Dadalti Fragoso, Mike Boggild, Miguel Ángel Macías-Islas, Clinical Neurology and Neurosurgery Maternal ImmunizationNeurological DisorderMedicineDisease-modifying DrugsMaternal Health	2012	77
Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients Denise S.M. Medrado da Costa, Joana Hygino, Thaís B. Ferreira, Journal of Neuroimmunology InflammationCytokineMultiple Sclerosis PatientsAutoimmune DiseaseImmune Cell Development	2016	56
Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis Vanessa Daccach Marques, Giordani Rodrigues dos Passos, María Fernanda Mendes, Arquivos de Neuro-Psiquiatria	2018	56
Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I Marzia Puccioni‐Sohler, Yoshihisa Yamano, María Rios, Neurology	2007	54

Page 1